"Now that each apprentice has made their own DXL antibody, the gloves are off. The success and ultimate winner will depend on his or her skills to characterize, summarize and present their findings to the panel. The heats on and I am not talking about the Arizona heat."
-Jeff Morhet, President and CEO

"The processes and instruments that were introduced to them this week are key tools for them to utilize during their research."
-Tom Kindt, Ph.D., Chief Scientific Officer

"Persistence, hard work, and exceptional notetaking never go unnoticed."
-Jur Strobos, M.D., Chief Medical Officer

"All of the apprentices have shown great enthusiasm, motivation and skill, however one has excelled in science and another individual has shown extreme dedication. I couldn't be happier with the quality of this group."
-Mike Russ, DXL702 Program Manager, LABapprentice Supervisor

"The interns learned the importance of determining concentration through running an OPA protein quantification assay. They also learned how to characterize the DXL625 conjugations that they previously made with Marty by performing an ELISA and testing the target binding on the Biacore machine."
-Andrew Lassen, InNexus Biotechnology Scientist